GW Pharmaceuticals stock rises 10% after beating revenue expectations for marijuana-derived drug
August 06, 2019 at 16:38 PM EDT
GW Pharmaceuticals PLC shares rose more than 10% in the extended session Tuesday, after the company reported better-than-expected sales from its cannabis-derived epilepsy treatment drug.